Hookipa Pharma Inc
NASDAQ:HOOK 4:00:00 PM EDT
| Market Cap (Intraday) | 84.11M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.78 |
| 50-Day MA | $0.74 |
| 200-Day MA | $0.67 |
Hookipa Pharma Inc Stock, NASDAQ:HOOK
350 Fifth Avenue, 72nd floor, Suite 7240, New York, New York 10118
United States of America
Phone: +43.1.890.6360
Number of Employees: 151
Description
HOOKIPA Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in developing pharmaceutical products to prevent and cure infectious diseases and cancer. The firm also focuses on immunotherapeutics based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. The company was founded by Rolf M. Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel D. Pinschewer in 2011 and is headquartered in New York, NY.